0310-4505 : Imjudo 25 mg/1.25ml Intravenous Injection, Solution
NDC: | 0310-4505 |
Labeler: | Astrazeneca Pharmaceuticals Lp |
Product Type: | Human Prescription Drug |
Drug Name: | Imjudo |
Dosage Form: | Intravenous Injection, Solution |
Application #: | BLA761289 |
Rev. Date: |
NDC Package Codes:
- 0310-4505-25: 1 VIAL IN 1 CARTON (0310‑4505‑25) > 1.25 ML IN 1 VIAL
Active Ingredients:
- Tremelimumab
Dosage Strength:
- 25 mg/1.25mL
Pharmaceutical Classes:
- CTLA-4-directed Antibody Interactions [MoA]
- CTLA-4-directed Blocking Antibody [EPC]
- Increased T Lymphocyte Activation [PE]
Related Products:
Based on records with the same trade name.- 0310-4535 Imjudo 300 mg/15ml Intravenous Injection, Solution by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0310-4500Next: 0310-4535 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.